
News|Articles|September 1, 2009
Formulary Digital Edition September 2009
P&T considerations in fashioning a knowledge base, action plan for cardiometabolic disorders and weight; Focus on golimumab; Drug Watch: Agents in late-stage development for the treatment of gastrointestinal disorders
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Zepbound linked to lower healthcare costs in older adults with obesity
2
FDA approves Gilead’s Bixlenvo, smallest single-tablet option for virologically suppressed HIV patients
3
Biosimilars provide modest cost savings for cancer patients, study finds
4
Employer health care costs projected to rise 9.5% in 2027, report finds
5













